Get the Daily Brief
Latest Biotech News
Frazier Life Sciences Closes $1.3 Billion Early-Stage Biotech Fund
Venture capital firm Frazier Life Sciences announced a successful closing of a $1.3 billion fund aimed at early-stage biotech startups. The oversubscribed fund will support company creation and...
AI Empowers Gene Editing Accuracy with CRISPR-GPT System
A multidisciplinary team from Stanford, Princeton, Google DeepMind, and UC Berkeley developed CRISPR-GPT, an AI system integrating large language models with expert knowledge to automate the...
New mRNA Delivery Method Targets Pancreas for Therapy in Diabetes, Cancer
Researchers at the University of Nevada, Las Vegas disclosed an innovative mRNA delivery technique enabling organ-specific targeting of the pancreas, offering promising applications in treating...
FDA Approves Lenz Therapeutics’ Presbyopia Eye Drop
Lenz Therapeutics received FDA approval for its presbyopia treatment, aceclidine-based eye drops, set to launch in the US next quarter. The new non-invasive option targets a largely underserved...
Ultromics Raises $55 Million to Expand AI Heart Failure Detection Platform
Ultromics Ltd. secured $55 million in Series C funding to enhance its AI-based cardiovascular disease detection technology. The capital will be deployed to broaden its U.S. market presence and...
Immune Strategy Blocking Fat Metabolism Activates B Cells to Suppress Liver Cancer
Published in Nature, a groundbreaking study from McMaster University and Espervita Therapeutics reveals that inhibiting ATP citrate lyase (ACLY), essential for fatty acid synthesis, remodels the...
Breakthrough White Blood Cell Proteomics Maps T-Cell Exhaustion Proteome
Dr. David Ezra Gordon’s lab at Emory University presented pioneering use of trapped ion mobility mass spectrometry to create a comprehensive proteomic and phosphoproteomic atlas of in vivo...
Vir Biotechnology Shifts Focus to Cancer, Infectious Diseases Post Setbacks
Vir Biotechnology has embarked on a pivot toward oncology and infectious disease therapeutics following commercial and clinical challenges. The company recently initiated a Phase I trial for...
FDA Leadership Shakeup Sends Pharma Stocks Tumbling
Vinay Prasad's abrupt resignation from the FDA's Center for Biologics Evaluation and Research (CBER) has elicited mixed reactions within the biotech sector. Prasad's tenure was marked by...
AI-Powered Advances in Gene Editing and Biomedical Research
Artificial intelligence continues to transform biotechnology with novel tools facilitating gene editing and biomedical analyses. Researchers have developed CRISPR-GPT, an AI system leveraging...
Respiratory Viral Infections Linked to Breast Cancer Metastasis
Groundbreaking research has revealed that common respiratory viruses, including SARS-CoV-2 and influenza, can reactivate dormant breast cancer cells in the lungs, potentially triggering...
Precision Medicine Breakthroughs in Liver and Kidney Disease
Recent studies have identified promising therapeutic strategies addressing liver and kidney pathologies. In liver cancer associated with metabolic dysfunction–associated steatohepatitis...
Large-Scale Venture Funding Signals Biotech Resilience
Despite a challenging funding landscape characterized by reduced overall investment and greater market caution, several leading life sciences venture firms have successfully raised substantial...
Innovative Immunotherapies and Cancer Diagnostic Tools Emerge
Cutting-edge developments in immuno-oncology and cancer diagnostics offer new optimism for patient management. ImmuneOnco and Instil Bio revealed early promising data from a PD-L1xVEGF bispecific...
GLP-1 Receptor Agonists and Obesity-Related Therapeutics Advance
GLP-1 receptor agonists continue to demonstrate efficacy beyond diabetes management. Eli Lilly’s Mounjaro matched older treatments in reducing cardiovascular outcomes and showed promising weight...
Proteomic and Molecular Insights into Neurodegeneration and Aging
Recent cutting-edge studies in neurobiology have yielded significant insights into molecular mechanisms underlying neurodegeneration and brain aging. Killifish models have revealed that...
Sustainable Agriculture and Microbiome Innovations
Agricultural research is advancing through novel initiatives harnessing microbiomes, genetic resources, and innovative pest control technologies. Studies highlight the impact of arbuscular...
Vir Biotechnology’s Strategic Pivot and Sanofi Collaboration in Immuno-Oncology
Following recent commercial and clinical challenges, Vir Biotechnology is aggressively progressing its cancer and infectious disease pipeline. In July 2025, Vir initiated a Phase I trial for...
FDA Leadership Shakeup Amid Sarepta Gene Therapy Controversy
Vinay Prasad abruptly departed his role as Director of the FDA’s Center for Biologics Evaluation and Research after a brief and contentious tenure marked by stringent regulatory decisions,...
Alnylam’s Amvuttra Rare Disease Drug Surges with Expanded Use
Alnylam Pharmaceuticals' Amvuttra, used for hereditary ATTR amyloidosis and a newly approved cardiovascular indication, reported second-quarter revenues reaching $492 million, over double prior...